Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

111
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
111
Wilcoxon Rank-Sum Test01:21

Wilcoxon Rank-Sum Test

124
The Wilcoxon rank-sum test, also known as the Mann-Whitney U test, is a nonparametric test used to determine if there is a significant difference between the distributions of two independent samples. This test is designed specifically for two independent populations and has the following key requirements:
124
Ranks01:02

Ranks

207
Unlike parametric methods, nonparametric statistics are ideal for nominal and ordinal data, requiring fewer assumptions about the population's nature or distribution. This makes nonparametric methods easier to apply and interpret, as they do not depend on parameters like mean or standard deviation. One common approach in nonparametric analysis is to sort data according to a specific criterion. For instance, we might arrange weather data from hottest to coldest days in a month or rank cities...
207
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

92
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
92
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

244
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
244
Bonferroni Test01:10

Bonferroni Test

2.6K
The Bonferroni test is a statistical test named after Carlo Emilio Bonferroni, an Italian mathematician best known for Bonferroni inequalities. This statistical test is a type of multiple comparison test to determine which means are different than the rest. Bonferroni test can minimize the Type 1 error by reducing the significance level alpha, which otherwise increases with sample pairs.
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
2.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Measurement properties of the interest in health scale among community-dwelling older adults in Japan: Verification of the 12-item, 6-item, and 4-item versions of the interest in health scale.

Preventive medicine reports·2026
Same author

Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-Bevacizumab.

Anticancer research·2026
Same author

Mid-treatment MRI-based tumor volume reduction rate as a continuous prognostic factor after chemoradiation for cervical cancer: development and two-center internal-external validation.

Journal of radiation research·2026
Same author

Response to "Reconsidering 'photon-ineligible' status in concurrent chemo-proton therapy for stage III non-small cell lung cancer".

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Physicochemical and functional properties of albumin fractions from barley and rye seed protein isolate.

Bioscience, biotechnology, and biochemistry·2026
Same author

Evaluation of tumor detection capability for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm in each MRI sequence.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same journal

A joint model for a longitudinal outcome and a progressive multistate model under a mixed observation scheme.

Statistical methods in medical research·2026
Same journal

Efficient semi-supervised estimation of optimal individualized treatment regimes with survival outcome.

Statistical methods in medical research·2026
Same journal

Asymptotic online FWER control for dependent test statistics.

Statistical methods in medical research·2026
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
查看所有相关文章

相关实验视频

Updated: May 16, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

基于变换的全球排名测试,用于多个主要终点的自适应权重.

Satoshi Yoshida1,2, Yusuke Yamaguchi3, Kazushi Maruo4

  • 1Data Science, Astellas Pharma Inc., Tokyo, Japan.

Statistical methods in medical research
|May 14, 2025
PubMed
概括
此摘要是机器生成的。

这项研究引入了一种新的全球排名测试,用于具有多个疗效终点的临床试验. 新方法有效地控制了I型错误率,并提供了更好的统计能力,特别是在相关的终点.

关键词:
多个终点的多个终点.全球测试测试全球测试测试双向比较 双向比较调配试验试验 调配试验小规模的临床试验.

更多相关视频

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

相关实验视频

Last Updated: May 16, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

科学领域:

  • 生物统计学 生物统计学
  • 临床试验设计 临床试验设计
  • 统计分析 统计分析

背景情况:

  • 临床试验经常评估多个疗效终点,需要仔细选择主要终点,以获得研究成功.
  • 全球测试是一种新兴的统计方法,用于同时分析多个终点,而不需要多重性调整.
  • 确定聚合终点统计数据的适当权重是全球测试方法学的关键挑战.

研究的目的:

  • 提出一种新的全球排名测试,旨在从研究数据中估计终点权重,最大限度地提高测试统计数据.
  • 与现有方法相比,评估拟议的全球排名测试的I型错误率控制和统计能力.
  • 评估拟议测试在各种场景中的性能,包括不同数量的终点和相关性水平.

主要方法:

  • 开发一种新的全球排名测试,通过当前研究数据自适应地估计终点权重.
  • 使用顺序测试以保持I型错误率在名义水平.
  • 进行模拟研究,以将拟议的测试与不同条件下的其他全球测试进行比较.

主要成果:

  • 拟议的全球排名测试有效地控制了不同数量的主要终点和相关结构的I型错误率.
  • 与其他全球测试相比,当终点疗效显著差异或当终点相对相关度中等 (相关系数≥0.5) 时,该测试显示出更高的统计能力.

结论:

  • 新型全球排名测试提供了一种强大而强大的方法,用于分析临床试验中的多个疗效终点.
  • 这种方法在具有异质终点效应或中度终点相关性的场景中提供了优势,提高了统计效率.